x
ServiziMenu principaleHome
You are here: Home > Events > Future Events > ESO Masterclass in Neuro-Oncology: Multidisciplinary Management of Adult Brain Tumours
Print

ESO Masterclass in Neuro-Oncology: Multidisciplinary Management of Adult Brain Tumours

08.10.2020  -  10.10.2020

Milan, Italy

MASTERCLASS

Neuro-oncology

Description

The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages in management of adult brain tumours. Participants will deliver case presentations within groups sessions: These sessions will also give to the participants the opportunity to exchange ideas with the experts about the proper management of the more problematic cases encountered in the daily practice while treating patients with brain tumours.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission.

LEARNING OBJECTIVES
• Improve of neurologists, radiation oncologists, medical oncologists and surgical oncologists/neuro-surgeons skills
• Practicing case discussions
• Update on the current standards of neurosurgery with special focus on intraoperative imaging, monitoring and neuro-navigation.
• Improve the knowledge on current radiotherapy standards and techniques (IMRT, stereotactic radiosurgery, protons, etc.)
• Update on epidemiology, combination of radiotherapy with surgery and drug therapy, clinical trials management

MAIN TOPICS
• Clinical management of patients with primary and metastatic brain tumors
• Technical improvements, altered fractionation, specific aspects of high precision radiotherapy, radiosurgery, chemo-sentitization and other aspects of medical therapy
• Supportive treatments, symptom control both in palliative and curative intent

TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and will conclude in take-home messages. The clinical sessions will be complemented by group discussions supported by the chairs and faculty.
Participants will be encouraged to deliver case presentations within small groups and discuss these with the chairs and the faculty.
All participants will reside at the course venue and participation will be expected to be present throughout the course.
The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.

THE MASTERCLASS IS:
• A 3-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• Delivered by an international faculty of experts

 

In collaboration with
         
Under the auspices
       







 

 
Endorsed by          

 

Faculty

FACULTY
R. Bhangoo, King's College Hospital NHS Foundation Trust, London, UK
M. Brada, University of Liverpool & Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, UK
J. Capitanio, San Raffaele University Health Institute, Milan, IT
P. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
A. Cianfoni, Neurocenter of Southern Switzerland, Lugano, CH
G. Finocchiaro, Istituto Neurologico Besta, Milan, IT
E. Franceschi, Azienda USL of Bologna - IRCCS Institute of Neurological Sciences, Bologna, IT
C. Gamondi, Oncology Institute of Sothern Switzerland, Bellinzona, CH
S. Grau, University Hospital Cologne, Cologne, DE
M. Hegi, Lausanne University Hospital (CHUV), Epalignes, CH
P. Mortini, San Raffaele University Health Institute, Milan, IT
A. Pellerino, City of Health and Science University Hospital, T urin, IT
G. Pesce, Oncology Institute of Sothern Switzerland, Bellinzona, CH
S. Presilla, Ente Ospedaliero Cantonale, Bellinzona, CH
M. Reinert, Neurocenter of Southern Switzerland, Lugano, CH
F. Roncaroli, University of Manchester, Manchester, UK
R. Rudà, University and City of Health and Science Hospial of Turin, Turin, IT
R. Soffietti, University and City of Health and Science Hospial of Turin, Turin, IT
S. Stacchiotti, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT

General information

ORGANISING SECRETARIAT
European School of Oncology
Piazza Indipendeza 2, 6500 Bellinzona, Switzerland
Luis Carvalho, Ph: +41 91 820 09 58, E-mail: lcarvalho@eso.net
Laura Richetti, Ph: +41 91 820 0951, E-mail: lrichetti@eso.net

ACCREDITATION
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the application can be obtained from the organising secretariat.
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.

ESCO CREDITS



Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.

A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.esco.org for information on how to join ESCO.

Application

PARTICIPANT’S PROFILE
• Neurologists , radiation oncologists, medical oncologists and surgical oncologists/neuro-surgeons with at least 2 years experience in neurosurgery, radiotherapy or neuro-oncology.
• Aged between 30 and 40 years
• Involvement in scientific activities (desirable)
• Fluency in English

PARTICIPATION
Attendance is limited to 50 participants and admittance is by competitive application only.
Successful applicants are granted free registration but a contribution to the costs of half board accommodation (farewell dinner included) at the course venue (EUR 200) is requested. Travel, arrival and departure transfers are to be covered by the participants.

HOW TO APPLY
Interested oncologists should apply online (at the top of this page) providing:
• Letter describing motivation for attending;
• Supporting letter from head of department or mentor;
• CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
• Clinical case (see below)

CLINICAL CASE PRESENTATION
Applicants are requested to submit an abstract describing a clinical case related to the subject of the Masterclass (form available at the bottom of this page).
It is suggested that, among the subject of the Masterclass, the clinical case is on a tumour type that the applicant does not see frequently but that could add to the overall educational contents of the Masterclass. On the contrary, it is recommended that the case reflects the participant’s daily practice, avoiding uncommon or extremely rare cases which may have a lower educational impact.
The clinical case abstract should include diagnostic considerations, treatment, results and follow-up, at least three questions proposed for discussion.
Admitted participants will have the opportunity to present the clinical case in the format of a clinical grand round discussion to the chairs, other faculty members and participants.

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
Successful applicants are granted free registration and half board accommodation
APPLICATION DEADLINE: 21 JUNE 2020

Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Abstract template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

TEMPLATES
• Download HERE your Professional experience template
•  Download HERE your Abstract template

Programme

8 October

12:30 Arrival and registration
13:00 Welcome and introduction to the course
G. Pesce, CH - P. Mortini, IT
13:20 Welcome by the local authority
OVERVIEW ON BRAIN TUMOURS
Chairs: A. Pesce, CH - P. Mortini, IT
 13:30 Taking care of patients with brain tumors
G. Pesce, CH
13:50 Discussion
BRAIN METASTATES
Chairs: P. Mortini, IT - TBC
 14:00 Neurosurgery of brain metastases: State of the art
Speaker TBC
14:30 Coffee break
15:00 Radiotherapy and radiosurgery for brain metastases: State of the art
M. Brada, UK
15:30 Medical therapies for patient with brain metastases
R. Soffietti, IT
16:00 Discussion
RARE TUMOURS
Chair: P. Casali, IT
16:20 Chordoma
S. Stacchiotti, IT
16:50 Medulloblastoma and other PNETS
E. Franceschi, IT
17:20 Group workshops
  Group 1 - Clinical cases presentation by the participants
G. Pesce, CH
Group 2 - Clinical cases presentation by the participants
P. Mortini, IT
Group 3 - Clinical Cases presentation by the participants
R. Soffietti, IT

9 October

INTRA-AXIAL PRIMARY BRAIN TUMORS: HIGH GRADE GLIOMAS AND LOWER GRADE GLIOMAS
Chairs: R. Bhangoo, UK - G. Pesce, CH
 8:30 Neuropathology: Current WHO classification (2016)
L. Bertero, IT
9:00 Epigenetic vunlnerabilities in glioma, biomarkers and new opportunities
M. Hegi, CH
9:30 Neuro imaging - updates
A. Cianfoni, CH
10:15 Coffee break
10:45 Neurosurgery: State of the art
R. Bhangoo, UK
11:15 Medical Therapies: Updates
R. Rudà, IT
11:45 Radiotherapy: State of the art
G. Pesce, CH
12:15 Discussion
12:30 Discipline oriented workshops
  Group 1 - Surgery: Techniques to optimize tumor resection (intraoperative ultrasound, hydodissection, neuronavigation, brain Mapping)
Chairs: J. Capitanio, IT - R. Bhangoo, UK
Group 2 - Radiotherapy planning: Exercise for cases of glioma and metastasis
Chairs: M. Brada, UK - G. Pesce, CH - S. Presilla, CH
13:30 Lunch
GLIOMAS 2: SPECIAL SITUATIONS
Chairs: R. Rudà, IT - C. Gamondi, CH
 14:30 Management of elderly patients with gliomas
A. Pellerino, IT
15:00 Treatment options for "inoperable" and recurrent gliomas: Is there a role for surgery?
P. Mortini, IT
15:30 Treatment options for recurrent gliomas: Is there a role for radiotherapy?
M. Brada, CH
16:00 Discussion
16:15 Coffee break
16:45 Group workshops
  Group 1 - Clinical cases presentation by the participants
Chair: R. Rudà, IT
Group 2 - Clinical case presentation by the participants
Chair: D. Bosetti, CH
Group 3 - Clinical case presentation by the participants
Chair: R. Bhangoo, UK
20:30 Farewell Dinner

10 October

EXTRA-AXIAL PRIMARY BRAIN TUMORS
Chairs: P. Mortini, IT - R. Soffietti, IT
 8:30 Neuropathology: Update in 2016 WHO classification
F. Roncaroli, UK
9:00 EANO guidelines on diagnosis and treatment options of EAPBT
S. Grau, DE
9:30 Neuro-surgery: State of the art
P. Mortini, IT
10:00 Coffee break
10:30 Radiation therapy: State of the art
D. Bosetti, CH
11:00 Medical therapy of meningeomas
R. Soffietti, IT
11:30 Tumor Board What to do with this meningeoma? Discusson of 2 challenging cases
All
SYSTEMIC TREATMENTS IN NEURO-ONCOLOGY
Chairs: G. Pesce, CH - R. Rudà, IT
 12:00 Targeted therapies
R. Rudà, IT
12:30 Results of clinical research and ongoing trials on immunotherapy
G. Finocchiaro, IT
13:00 Discussion
13:10 Best cases awards
G. Pesce, CH - P. Mortini, IT
13:20 Closing remarks
G. Pesce, CH - P. Mortini, IT
13:30 Lunch followed by departures

 

Follow us